http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103083684-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ce61bf06f294f2f466c067ed41cc8ce |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
filingDate | 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50c997567efaac211f7dbee3b2e8c0a |
publicationDate | 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103083684-B |
titleOfInvention | Method for improving immune protective rate of fasciola hepatica Cat L1 (FhCat L1) DNA (Deoxyribose Nucleic Acid) vaccine |
abstract | The invention provides a method for improving immune protective rate of a fasciola hepatica Cat L1 (FhCat L1) DNA (Deoxyribose Nucleic Acid) vaccine. The method is carried out based on the presenting effect of the antigen in dendritic cells, the influential role mechanism that the single-chain antibody scFvNLDC-145 of the DEC-205 of surface molecules of dendritic cells (DC) can target the DC cells is utilized, so that the resistance of a Spragae-Dawley rat to fasciola hepatica infection subjected to the immune encoding of the DNA vaccine of the FhCat L1 is improved, and as a result, the immune protective rate of the DNA vaccine of the FhCat L1 is improved. |
priorityDate | 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 495.